Dr. Sarah Charney | DVM, DACVIM (O), DACVR (RO)

Dr. Sarah Charney is a veterinary medical oncologist and radiation oncologist. She is a founding partner of Boundary Bay Veterinary Specialty Hospital. Dr. Charney is passionately committed to providing cancer care with compassion for both her animal patients and their families. Dr. Charney believes that quality of life is paramount and works to ensure that her patients live as long as possible while still enjoying life.

Dr. Sarah Charney’s primary areas of interest include researching new chemotherapeutics, providing compassionate cancer care, and using radiosurgery to increase efficacy and decrease side effects of radiation.

Dr. Charney enjoys gourmet cooking, reading, hiking, boating and most of all, spending time with her daughters Cecelia, Madeleine and Johanna.

Dr. Charney looks forward to being part of the extended Boundary Bay Veterinary Specialty Hospital veterinary family that includes clients, patients, referring veterinarians, and all those who care about animals as much as we do.

Board Certifications

  • American College of Veterinary Internal Medicine (Oncology)
  • American College of Veterinary Radiology (Radiation Oncology)

Education

  • University of Chicago, Bachelor of Arts in Biology
  • University of Illinois, Doctor of Veterinary Medicine
  • University of Missouri, Internship in Small Animal Medicine and Surgery
  • Animal Medical Center, Oncology Residency
  • Southwest Veterinary Oncology, Radiation Oncology Residency

Memberships

  • Veterinary Cancer Society
  • CyberKnife Society
  • College of Veterinarians of British Columbia
  • American Veterinary Medical Association
  • Canadian Veterinary Medical Association

Awards

  • University of Missouri Phi Zeta Award for Clinical Research by an Intern
  • Connie Leifer Award for Outstanding Resident Research

Areas of Clinical Research

  • Clinical research of the melanoma vaccine later approved by the FDA as the Merial Melanoma Vaccine®.
  • Clinical research on aminobisphosphonates, epidermal growth factor inhibitors, and non-steroidal anti-inflammatory drugs as treatments in tumor-bearing animals
  • Participant in clinical trials for both Cerenia® and Palladia®.
  • Involved in development and testing of a Z-plate system to accurately localize tumors for radiation
  • Clinical research regarding efficacy of CyberKnife radiosurgery for the treatment of cancer in dogs and cats

Concurrent Positions

  • Adjunct Professor, University of Illinois
  • Director of CyberKnife Radiation, Animal Specialty Center
  • Radiation Oncologist, DMV Montreal

Publications

View Dr. Sarah Charney’s Publications

Recent Invited Presentations

  • CyberKnife Radiosurgery in Dogs and Cats, Veterinary Cancer Society Annual Meeting
  • CyberKnife Radiosurgery for Brain Tumors, ACVIM Annual Forum
  • Advances in Radiation Therapy, ACVR Annual Meeting